Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 3
They don't really have competition.

Theyre integrating into EMR, reducing headaches on medical providers. They own transplant markets and doing gobs of research. High margin business too.

There's alot to like here. This honestly could/should be a rule breaker or Saul stock.

It's growing 50% or more yoy with 70% margins. Saas companies are 20-35x price:sales with margins this high. At 200m/year, 20x puts them at about 4b, which is where they are currently valued. With a TAM in the billions- and very likely to hit that number in the next 5 or so years- CareDx seems like it could be a pretty safe set it and forget it winner.

If there is a sure thing in biotech, this comes awfully close. I struggle to see how this doesn't outperform over the next 3-5 years even after it's recent run up.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.